Abbvie Inc (NYSE:ABBV)
| 149.88 BATS BZX Real-Time Price As of 11:27am ET |  -1.84 / -1.21%Today’s Change | 105.56 Today|||52-Week Range 175.91 | +10.69% Year-to-Date |
Latest ABBV News | Press Releases
Today’s Trading
| Previous close | 151.72 |
| Today’s open | 151.66 |
| Day’s range | 149.72 - 153.48 |
| Volume | 1,318,463 |
| Average volume (3 months) | 7,919,000 |
| Market cap | $271.3B |
Data as of 11:27am ET, 05/20/2022
Growth & Valuation
| Earnings growth (last year) | +137.07% |
| Earnings growth (this year) | +10.78% |
| Earnings growth (next 5 years) | +1.90% |
| Revenue growth (last year) | +22.69% |
| P/E ratio | 21.5 |
| Price/Sales | 4.28 |
| Price/Book | 17.62 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| LLYEli Lilly and Co | +8.79 | +3.07% |
| PFEPfizer | +1.31 | +2.59% |
| MRKMerck | +0.81 | +0.88% |
| AZNAstraZeneca | +1.34 | +2.08% |
Data as of 11:28am ET, 05/20/2022
Financials
| Next reporting date | July 29, 2022 |
| EPS forecast (this quarter) | $3.43 |
| Annual revenue (last year) | $56.2B |
| Annual profit (last year) | $11.5B |
| Net profit margin | 20.41% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters North Chicago, Illinois |
Forecasts
